Delivery Order SPE2DB20D2014-SPE2DB25FA78E
Award Date
1/13/25
Potential Completion Date
1/14/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL81T, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S, with a ceiling value of $10,457.45. This is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $3,239.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of LINZESS 145 MCG CAPSULE UU 30S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., will supply these essential pharmaceutical products to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,102.22, is a Delivery Order for the provision of LINZESS 145 MCG CAPSULE medication. The award has an ultimate completion date of November 4, 2024 and is a Firm Fixed Price contract. This order is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide LINZESS 290 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $1,484.48. The ultimate completion date is July 29, 2024. This appears to be a contract under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of LINZESS 145 MCG CAPSULE medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,089.86, and has an ultimate completion date of June 25, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $2,227.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product.
The contract has an ultimate completion date of August 26, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025. This IDC enables the...
This federal contract award, valued at $10,594.27, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S pharmaceutical product. This appears to be a one-time delivery order rather than a larger indefinite delivery contract vehicle. The contract is a firm fixed-price arrangement, with an ultimate completion date of August 22, 2022. The place of performance is Conshohocken, PA....
This federal contract award is for the delivery of LINZESS 145 MCG capsules to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,543.27 and a completion date of November 4, 2024. It is a delivery order contract, with no set-aside designation.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LINZESS 290 MCG capsules. The $1,205.25 firm fixed price delivery order has a completion date of November 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of LINZESS 290 MCG capsules. The contract has a ceiling value of $1,870.48 and an ultimate completion date of May 14, 2024. This is a delivery order contract with a firm fixed price pricing type.
Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...